“Chemotherapy will become just a bad memory”

I reported previously (3rd Sep) of Gilead’s $11.9 billion buyout of Kite – a biotech founded by Israel’s Professor Arie Belldegrun. Kite’s CAR-T technology cures non-Hodgkin lymphoma that kills 7,000 patients annually in the US alone. Prof Belldegrun gave his first interview since the deal.

http://www.globes.co.il/en/article-chemotherapy-will-become-just-a-bad-memory-1001206978

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *